PharmaSGP Holding SE | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
PharmaSGP Holding SE

BRIEF

published on 04/16/2024 at 07:35, 7 months 5 days ago

PharmaSGP Achieves Over €100 Million in Revenues for 2023, Eyes Expansion in 2024

Revenue Increase EBITDA 2024 Forecast Financial Growth PharmaSGP
PRESS RELEASE

published on 04/16/2024 at 07:30, 7 months 5 days ago

PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP surpasses €100 million revenues in 2023, plans growth in 2024. Achieved 17.8% revenue increase and 20.8% rise in adjusted EBITDA. Forecasts €107-112 million revenues and €35-38 million EBITDA for 2024

Revenues Adjusted EBITDA Growth 2024 Forecast PharmaSGP
PRESS RELEASE

published on 09/14/2023 at 07:30, 1 year 2 months ago

PharmaSGP achieves top performance in the first half of 2023
PRESS RELEASE

published on 06/29/2023 at 07:30, 1 year 4 months ago

PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
PRESS RELEASE

published on 05/10/2023 at 07:30, 1 year 6 months ago

PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%
PRESS RELEASE

published on 04/19/2023 at 07:30, 1 year 7 months ago

PharmaSGP plans dividend distribution of 49.2% after record year in 2022
PRESS RELEASE

published on 03/15/2023 at 07:30, 1 year 8 months ago

PharmaSGP confirms record revenue and record profitability for 2022 and publishes forecast for 2023
PRESS RELEASE

published on 03/14/2023 at 18:17, 1 year 8 months ago

EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
PRESS RELEASE

published on 02/20/2023 at 07:30, 1 year 9 months ago

PharmaSGP achieves new record revenue of more than € 85.5 million for 2022 exceeding analysts’ expectations
PRESS RELEASE

published on 01/03/2023 at 16:13, 1 year 10 months ago

EQS-Adhoc: PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro

Accesswire

Published on 11/21/2024 at 14:15, 17 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 32 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 32 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 32 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 32 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 16 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 17 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 32 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 17 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 57 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 34 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 12 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE